FDA issued a Warning Letter to Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy on 1/13/2020 as a result of this inspection.
483 Anderson Compounding Pharmacy DBA Anderson Compounding Apr 2019

483 Anderson Compounding Pharmacy DBA Anderson Compounding Apr 2019

June Page FDA, Xiaohui Shen FDA$119.00 - Available Now

FDA investigators audited the Anderson Compounding Pharmacy DBA Anderson Compounding - Bristol, TN, United States facility and issued inspectional observations (via FDA 483) on 05 Apr 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 05 Apr 2019
  • Location: Bristol, United States
  • FEI: 3014877770
Add To Cart